Search research articles
Contact Us
Filters
Showing results (171-180 of 193) with videos related to
Page
of 20
Sort By:
Circulation Research
|
October 30, 2012
Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling
Xiaoying Zhang, Christopher Szeto, Erhe Gao, et al.
Bioorganic & Medicinal Chemistry
|
January 25, 2023
Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
Gang Lv, Qiong Shi, Ting Zhang, et al.
Bioorganic & Medicinal Chemistry
|
April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling
Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series
Longbin Liu, Mark H Norman, Matthew Lee, et al.
Nature Communications
|
February 27, 2021
A CSB-PAF1C axis restores processive transcription elongation after DNA damage repair
Diana van den Heuvel, Cornelia G Spruijt, Román González-Prieto, et al.
Journal of Medicinal Chemistry
|
July 1, 2011
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability
Markian M Stec, Kristin L Andrews, Shon K Booker, et al.
Bioorganic & Medicinal Chemistry
|
May 29, 2016
Corrigendum to "Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling" [Bioorg. Med. Chem. 24 (2016) 2215-2234]
Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Urologic Oncology
|
January 21, 2020
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset
Alessandro Veccia, Alessandro Antonelli, Andrea Minervini, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 27, 2012
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold
Ryan P Wurz, Longbin Liu, Kevin Yang, et al.
Frontiers in Molecular Biosciences
|
March 7, 2022
iCn3D: From Web-Based 3D Viewer to Structural Analysis Tool in Batch Mode
Jiyao Wang, Philippe Youkharibache, Aron Marchler-Bauer, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 193) with videos related to
Sort By:
Page
of 20
Circulation Research
|
October 30, 2012
Cardiotoxic and cardioprotective features of chronic β-adrenergic signaling
Xiaoying Zhang, Christopher Szeto, Erhe Gao, et al.
Bioorganic & Medicinal Chemistry
|
January 25, 2023
Integrating a phenotypic screening with a structural simplification strategy to identify 4-phenoxy-quinoline derivatives to potently disrupt the mitotic localization of Aurora kinase B
Gang Lv, Qiong Shi, Ting Zhang, et al.
Bioorganic & Medicinal Chemistry
|
April 18, 2016
Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling
Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Journal of Medicinal Chemistry
|
February 11, 2012
Structure-based design of novel class II c-Met inhibitors: 2. SAR and kinase selectivity profiles of the pyrazolone series
Longbin Liu, Mark H Norman, Matthew Lee, et al.
Nature Communications
|
February 27, 2021
A CSB-PAF1C axis restores processive transcription elongation after DNA damage repair
Diana van den Heuvel, Cornelia G Spruijt, Román González-Prieto, et al.
Journal of Medicinal Chemistry
|
July 1, 2011
Structure-activity relationships of phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dual inhibitors: investigations of various 6,5-heterocycles to improve metabolic stability
Markian M Stec, Kristin L Andrews, Shon K Booker, et al.
Bioorganic & Medicinal Chemistry
|
May 29, 2016
Corrigendum to "Purinylpyridinylamino-based DFG-in/αC-helix-out B-Raf inhibitors: Applying mutant versus wild-type B-Raf selectivity indices for compound profiling" [Bioorg. Med. Chem. 24 (2016) 2215-2234]
Longbin Liu, Matthew R Lee, Joseph L Kim, et al.
Urologic Oncology
|
January 21, 2020
Upstaging to pT3a disease in patients undergoing robotic partial nephrectomy for cT1 kidney cancer: Outcomes and predictors from a multi-institutional dataset
Alessandro Veccia, Alessandro Antonelli, Andrea Minervini, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 27, 2012
Synthesis and structure-activity relationships of dual PI3K/mTOR inhibitors based on a 4-amino-6-methyl-1,3,5-triazine sulfonamide scaffold
Ryan P Wurz, Longbin Liu, Kevin Yang, et al.
Frontiers in Molecular Biosciences
|
March 7, 2022
iCn3D: From Web-Based 3D Viewer to Structural Analysis Tool in Batch Mode
Jiyao Wang, Philippe Youkharibache, Aron Marchler-Bauer, et al.
Page
of 20